Molecular Oncology and Pathology
Molecular genetic testing has become the primary tool for precision medicine. With one of the fastest development cycles in the industry, NeoGenomics is committed to providing a full complement of clinically relevant diagnostic, predictive, and prognostic tests, and to helping our clients effectively incorporate these tests into the care of their patients.
Highlights of our molecular services
Our development program
Our molecular service offerings continue to expand at a rapid rate and have positioned NeoGenomics as the industry leaders in molecular testing. We are accomplishing this in three main ways:
The year 2014 brings continued growth and a focus on improving efficiency and cost-effectiveness through the additions of new targeted profiles and technology platforms. For example, with its NeoTYPE™ Cancer Profiles and Next-Generation Sequencing capabilities, NeoGenomics provides a unique set of analyses targeted to specific tumor types that identify the genetic changes most significant to therapy decisions, prognosis and clinical research.
Recently added tests
These tests were recently added to our menu. Test details and specimen requirements may be viewed and printed via the following links.
See our full list of molecular tests with printable descriptions and specimen requirements.
Subscribe to our mailing list to receive email notifications of new tests.
Download our molecular brochure with test menu.